has found that hormone levels, measured through blood tests, are an important indicator of whether women will benefit from recently licensed medication for the prevention of breast cancer. Research ...
Darbepoetin Alfa for the Treatment of Anemia in Patients With Active Cancer Not Receiving Chemotherapy or Radiotherapy: Results of a Phase III, Multicenter, Randomized, Double-Blind, ...
Share on Pinterest Anastrozole can reduce breast cancer risk after menopause, but does it come with its own risks? Image credit: shironosov/Getty Images. A drug used as a breast cancer treatment has ...
Post-menopausal women in the UK who are at a higher risk of breast cancer may soon have wider access to a medicine called anastrozole to reduce their chance of developing it. The drug, which is taken ...
The news that the U.K. has approved a preventive drug for post-menopausal women at risk of developing breast cancer wasn’t a shock to breast medical oncologist Abenaa Brewster. But the fact that a ...
A new study published in The Lancet Oncology discusses the efficacy of anastrozole, a molecule used to prevent breast cancer in postmenopausal women with a high risk of breast cancer. Study: Effect of ...
Anastrozole may stop breast cancer before it starts. fizkes/ Shutterstock A drug that can halve the risk of developing breast cancer in post-menopausal women has been approved for use in the UK. This ...
Studying the possible association between AI and cognitive dysfunction has accelerated over the past 7 years. A pilot study using neuropsychological testing from the Arimidex, Tamoxifen, Alone or in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results